A 17-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Of Pregabalin For The Treatment Of Chronic Central Neuropathic Pain After Spinal Cord Injury
A 17-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Of Pregabalin For The Treatment Of Chronic Central Neuropathic Pain After Spinal Cord Injury
The purpose of this study is to evaluate if pregabalin relieves nerve pain associated with spinal cord injury compared to placebo (pill that contains no active medicine). This study will also evaluate the safety of pregabalin in this patient population.
Inclusion Criteria:
Exclusion Criteria:
Secunderabad, Andhra Pradesh 500 003, India
Sasima-gun, Ibaraki, Japan
Kikuchi-gun, Kumamoto, Japan
Kotoku, Tokyo, Japan
Musashimurayama-shi, Tokyo, Japan
Higashiokitama-gun, Yamagata, Japan